- Home
- BOXL vs SONN Comparison
BOXL vs SONN Comparison
Compare BOXL & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOXL
- SONN
- Stock Information
- Founded
- BOXL 1985
- SONN N/A
- Country
- BOXL United States
- SONN United States
- Employees
- BOXL N/A
- SONN N/A
- Industry
- BOXL Telecommunications Equipment
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- BOXL Telecommunications
- SONN Health Care
- Exchange
- BOXL Nasdaq
- SONN Nasdaq
- Market Cap
- BOXL 3.9M
- SONN 3.8M
- IPO Year
- BOXL 2017
- SONN N/A
- Fundamental
- Price
- BOXL $1.83
- SONN $1.23
- Analyst Decision
- BOXL Buy
- SONN Strong Buy
- Analyst Count
- BOXL 3
- SONN 1
- Target Price
- BOXL $5.00
- SONN $20.00
- AVG Volume (30 Days)
- BOXL 16.5K
- SONN 50.9K
- Earning Date
- BOXL 08-06-2025
- SONN 08-13-2025
- Dividend Yield
- BOXL N/A
- SONN N/A
- EPS Growth
- BOXL N/A
- SONN N/A
- EPS
- BOXL N/A
- SONN N/A
- Revenue
- BOXL $121,223,000.00
- SONN $1,000,000.00
- Revenue This Year
- BOXL N/A
- SONN $5,376.22
- Revenue Next Year
- BOXL N/A
- SONN N/A
- P/E Ratio
- BOXL N/A
- SONN N/A
- Revenue Growth
- BOXL N/A
- SONN 978.39
- 52 Week Low
- BOXL $1.06
- SONN $1.08
- 52 Week High
- BOXL $10.65
- SONN $10.02
- Technical
- Relative Strength Index (RSI)
- BOXL 51.44
- SONN 56.97
- Support Level
- BOXL $1.72
- SONN $1.10
- Resistance Level
- BOXL $1.89
- SONN $1.17
- Average True Range (ATR)
- BOXL 0.13
- SONN 0.07
- MACD
- BOXL -0.01
- SONN 0.01
- Stochastic Oscillator
- BOXL 41.51
- SONN 86.00
About BOXL Boxlight Corporation
Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.